FluroTech

FluroTech Short-term Debt

Short-Term Debt of FluroTech (TEST.H.V) as of Nov 16, 2026.

Short-term Debt

0.00CAD

Last updated:

Short-Term Debt of FluroTech is 2024 0.00 CAD. Short-Term Debt of FluroTech was 2023 132,300.00 CAD. It decreases by % lower compared to the previous year.

The FluroTech Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2017
0.00 CAD
Jan 1, 2018
0.00 CAD
Jan 1, 2019
0.00 CAD
Jan 1, 2020
0.00 CAD
Jan 1, 2021
126,800.00 CAD
Jan 1, 2022
135,400.00 CAD
Jan 1, 2023
132,300.00 CAD
Jan 1, 2024
0.00 CAD
The FluroTech Short-term Debt history
YEARShort-term DebtYoY
0.00CAD-100.00%
132,300.00CAD-2.29%
135,400.00CAD+6.78%
126,800.00CAD—
0.00CAD—
0.00CAD—
0.00CAD—
0.00CAD—
0.00CAD—
0.00CAD—
0.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

FluroTech Stock analysis

What does FluroTech do? FluroTech Ltd. commercializes fluorescence spectroscopy technology for pandemic defense through its subsidiary FluroTest Diagnostics Systems Ltd., which develops rapid antigen testing platforms for SARS-CoV-2 and other pathogens. The company targets high-traffic environments such as schools, hospitals, stadiums, and corporate campuses with its FluroTest system, utilizing robotics automation, biochemistry, fluorescence detection, and cloud computing to deliver results. FluroTest Diagnostics Systems Ltd. focuses on high-output rapid antigen testing for pandemic defense, serving sectors including healthcare, education, and public venues. The primary buyers of FluroTech's technology are institutions requiring rapid pathogen detection in high-traffic settings, including schools, colleges, hospitals, athletic venues, and corporate campuses. These organizations purchase the FluroTest system to manage pandemic risks through automated, high-volume testing solutions. The company's revenue streams are derived from the sale and deployment of its diagnostic platform across these institutional segments. FluroTech Ltd. leverages its subsidiary FluroTest Diagnostics Systems Ltd. to commercialize the PEDDP (pandemic and emerging disease defense platform), which is designed for environments like airports, cruise terminals, and shopping centers. The company's products are sold to entities needing rapid, scalable testing solutions for SARS-CoV-2 and other pathogens, with the focus on institutional rather than individual consumers. FluroTech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about FluroTech stock

On Eulerpool you can find the complete historical development of Short-Term Debt FluroTech since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's FluroTech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — FluroTech

All Key Metrics — FluroTech